Literature DB >> 1148910

A long-term evaluation of silicone retinopathy in monkeys.

N Mukai, P F Lee, M Oguri, C L Schepens.   

Abstract

Six owl monkeys were exposed intravitreally for 6 to 28 months to Dow Corning Medical Fluid 350 in a morphologic study of silicone retinopathy. Fellow eyes of each silicone-injected animal and six eyes from three normal untreated monkeys served as controls. In addition, two eyes were treated post-mortem with silicone oil to insure that no artefact redistribution occurred. Each case was studied histochemically in frozen sections, with electron microscopy of Epon-embedded materials. All silicone-injected eyes showed numerous empty spaces in the inner segment of the retina adjacent to the vitreoretinal interface, corresponding to the intercellular spaces between Müller's filbers. These spaces contained numerous spherical bodies encircled by a homogeneous electron-opaque material, suggesting a silicone-phospholipid complex. Marked degeneration of small ganglion cells was seen. Müller's fibers appeared to be shrivelled. The lack of phospholipids in the inner segment of the visual receptors was marked, although no significant morphologic lesions were detectable. Abnormally high ATPase activity was found in both plexiform layers. There were no such lesions in the untreated control eyes, nor any detectable artefactual redistribution of silicone oil in the eyes treated post-mortem with Medical Fluid 350.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148910

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  16 in total

1.  PVA/STMP based hydrogels as potential substitutes of human vitreous.

Authors:  Gemma Leone; Marco Consumi; Marianna Aggravi; Alessandro Donati; Stefania Lamponi; Agnese Magnani
Journal:  J Mater Sci Mater Med       Date:  2010-05-25       Impact factor: 3.896

2.  Massive periretinal proliferation: a logical approach to therapy.

Authors:  R Machemer
Journal:  Trans Am Ophthalmol Soc       Date:  1977

3.  Histopathological findings in eyes after silicone oil injection.

Authors:  B Kirchhof; U Tavakolian; H Paulmann; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  The influence of intravitreously injected silicone oil on electrophysiological potentials of the eye.

Authors:  A Thaler; M R Lessel; H Gnad; P Heilig
Journal:  Doc Ophthalmol       Date:  1986-01-31       Impact factor: 2.379

5.  Experimental retinal tolerance to very low viscosity silicone oil (100 cs) as a vitreous substitute compared to higher viscosity silicone oil (5000 cs).

Authors:  M Soheilian; G A Peyman; T Moritera; H Wafapoor
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

6.  Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: results at six months.

Authors:  P K Leaver; R J Cooling; E B Feretis; J S Lean; D McLeod
Journal:  Br J Ophthalmol       Date:  1984-06       Impact factor: 4.638

7.  Electroretinographic studies following vitrectomy and intraocular silicone oil injection.

Authors:  T A Meredith; D T Lindsey; H F Edelhauser; A I Goldman
Journal:  Br J Ophthalmol       Date:  1985-04       Impact factor: 4.638

8.  Multifocal electroretinogram in eyes with intravitreal silicone oil and changes following silicone oil removal.

Authors:  Devesh Kumawat; Pranita Sahay; Karthikeyan Mahalingam; S J Vikas; Sagnik Sen; Mousumi Banerjee; Pradeep Venkatesh
Journal:  Doc Ophthalmol       Date:  2019-07-20       Impact factor: 2.379

9.  Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.

Authors:  R H Y Asaria; C H Kon; C Bunce; C S Sethi; G A Limb; P T Khaw; G W Aylward; D G Charteris
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

10.  Regular silicone and fluorosilicone oil in the prevention of retinal detachment caused by experimental proliferative vitreoretinopathy.

Authors:  A Alghadyan; G A Peyman; C Fizer; M Tawakol; K R Liu; B Yue; J H Peace
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.